NeuroOne Medical Technologies (NMTC) said late Thursday it began a proposed underwritten registered public offering of its shares.
The company will sell all the shares of common stock in the offering.
In addition, the company intends to grant the underwriter a 45-day option to purchase up to an additional 15% of the shares sold in the offering.
Shares NeuroOne Medical were down over 36% in after-hours activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。